Exercise Training Attenuates Upregulation of p47phox and p67phox in Hearts of Diabetic Rats

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Sharma, Neeru M ^a   Rabeler, Brandon ^a   Zheng, Hong ^a   Raichlin, Eugenia ^b   Patel, Kaushik P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART; HISTOLOGY; TISSUE;

BENEFICIAL EFFECTS; CARDIAC FUNCTIONS; CARDIAC REMODELING; DIABETIC CARDIOMYOPATHY; MOLECULAR MECHANISM; NADH/NADPH OXIDASE; REACTIVE OXYGEN SPECIES; REGULATORY SUBUNITS;

RATS;

COLLAGEN TYPE 3; PROTEIN P47; PROTEIN P67; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; NEUTROPHIL CYTOSOLIC FACTOR 1; OXIDOREDUCTASE; P67PHOX PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; HEART; HEART ATRIUM; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; DIABETIC CARDIOMYOPATHY; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MYOCARDIUM; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84959257422     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/5868913     Document Type: Article

References (85)

1. S. Dandamudi, J. Slusser, D. W. Mahoney, M. M. Redfield, R. J. Rodeheffer, and H. H. Chen, "The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota," Journal of Cardiac Failure, vol. 20, no. 5, pp. 304-309, 2014.
2. R. B. Devereux, M. J. Roman, M. Paranicas et al., "Impact of diabetes on cardiac structure and function: the Strong Heart study," Circulation, vol. 101, no. 19, pp. 2271-2276, 2000.
3. A. Ilercil, R. B. Devereux, M. J. Roman et al., "Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart study," American Heart Journal, vol. 141, no. 6, pp. 992-998, 2001.
4. S. Rubler, J. Dlugash, Y. Z. Yuceoglu, T. Kumral, A. W. Branwood, and A. Grishman, "New type of cardiomyopathy associated with diabetic glomerulosclerosis," The American Journal of Cardiology, vol. 30, no. 6, pp. 595-602, 1972.
5. S. Boudina and E. D. Abel, "Diabetic cardiomyopathy revisited," Circulation, vol. 115, no. 25, pp. 3213-3223, 2007.
6. A. Aneja, W. H. W. Tang, S. Bansilal, M. J. Garcia, and M. E. Farkouh, "Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options," American Journal of Medicine, vol. 121, no. 9, pp. 748-757, 2008.
7. I. Falcão-Pires and A. F. Leite-Moreira, "Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment," Heart Failure Reviews, vol. 17, no. 3, pp. 325-344, 2012.
8. J. W. Baynes and S. R. Thorpe, "Role of oxidative stress in diabetic complications: a new perspective on an old paradigm," Diabetes, vol. 48, no. 1, pp. 1-9, 1999.
9. D. Giugliano, A. Ceriello, and G. Paolisso, "Oxidative stress and diabetic vascular complications," Diabetes Care, vol. 19, no. 3, pp. 257-267, 1996.
10. T. Yu, S.-S. Sheu, J. L. Robotham, and Y. Yoon, "Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species," Cardiovascular Research, vol. 79, no. 2, pp. 341-351, 2008.
11. S. Boudina, H. Bugger, S. Sena et al., "Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart," Circulation, vol. 119, no. 9, pp. 1272-1283, 2009.
12. Y. Teshima, N. Takahashi, S. Nishio et al., "Production of reactive oxygen species in the diabetic heart: roles of mitochondria and NADPH oxidase," Circulation Journal, vol. 78, no. 2, pp. 300-306, 2014.
13. M. M. Dallak, D. P. Mikhailidis, M. A. Haidara et al., "Oxidative stress as a common mediator for apoptosis induced-cardiac damage in diabetic rats," Open Cardiovascular Medicine Journal, vol. 2, no. 1, pp. 70-78, 2008.
14. N. Takahashi, O. Kume, O. Wakisaka et al., "Novel strategy to prevent atrial fibrosis and fibrillation," Circulation Journal, vol. 76, no. 10, pp. 2318-2326, 2012.
15. R. J. Gryglewski, R. M. J. Palmer, and S. Moncada, "Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor," Nature, vol. 320, no.6061, pp. 454-456, 1986.
16. A. Mugge, J. H. Elwell, T. E. Peterson, and D. G. Harrison, "Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity," The American Journal of Physiology - Cell Physiology, vol. 260, no. 2, part 1, pp. C219-C225, 1991.
17. B. Tesfamariam and R. A. Cohen, "Enhanced adrenergic neurotransmission in diabetic rabbit carotid artery," Cardiovascular Research, vol. 29, no. 4, pp. 549-554, 1995.
18. Z. S. Katusic and P. M. Vanhoutte, "Superoxide anion is an endothelium-derived contracting factor," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 257, no. 1, part 2, pp. H33-H37, 1989.
19. P. H. Sugden and A. Clerk, "Cellular mechanisms of cardiac hypertrophy," Journal of Molecular Medicine, vol. 76, no. 11, pp. 725-746, 1998.
20. A. Akki, M. Zhang, C. Murdoch, A. Brewer, and A. M. Shah, "NADPH oxidase signaling and cardiac myocyte function," Journal of Molecular and Cellular Cardiology, vol. 47, no. 1, pp. 15-22, 2009.
21. K. K. Griendling, D. Sorescu, and M. Ushio-Fukai, "NAD(P)H oxidase: role in cardiovascular biology and disease," Circulation Research, vol. 86, no. 5, pp. 494-501, 2000.
22. H. D. Wang, S. Xu, D. G. Johns et al., "Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice," Circulation Research, vol. 88, no. 9, pp. 947-953, 2001.
23. J.-M. Li and A. M. Shah, "Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase," Cardiovascular Research, vol. 52, no. 3, pp. 477-486, 2001.
24. A. Cave, D. Grieve, S. Johar, M. Zhang, and A. M. Shah, "NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology," Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 360, no. 1464, pp. 2327-2334, 2005.
25. phox may participate in forming this oxidase in vitro and in vivo," Journal of Biological Chemistry, vol. 274, no. 28, pp. 19814-19822, 1999.
26. K. P. Patel, W. G. Mayhan, K. R. Bidasee, and H. Zheng, "Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion," American Journal of Physiology - Regulatory Integrative and Comparative Physiology, vol. 300, no. 2, pp. R311-R320, 2011.
27. H. M. Siragy, "AT(1) and AT(2) receptors in the kidney: role in disease and treatment," American Journal of Kidney Diseases, vol. 36, no. 3, supplement 1, pp. S4-S9, 2000.
28. J. R. Sowers, M. Epstein, and E. D. Frohlich, "Diabetes, hypertension, and cardiovascular disease - an update," Hypertension, vol. 37, no. 4, pp. 1053-1059, 2001.
29. V. Koshkin, O. Lotan, and E. Pick, "The cytosolic component p47(phox) is not a sine qua non participant in the activation of NADPH oxidase but is required for optimal superoxide production," The Journal of Biological Chemistry, vol. 271, no. 48, pp. 30326-30329, 1996.
30. H. M. Siragy, A. Awad, P. Abadir, and R. Webb, "The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats," Endocrinology, vol. 144, no. 6, pp. 2229-2233, 2003.
31. K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, "Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells," Circulation Research, vol. 74, no. 6, pp. 1141-1148, 1994.
32. M. E. Cifuentes, F. E. Rey, O. A. Carretero, and P. J. Pagano, "Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 279, no. 5, pp. H2234-H2240, 2000.
33. D. Lang, S. I. Mosfer, A. Shakesby, F. Donaldson, and M. J. Lewis, "Coronary microvascular endothelial cell redox state in left ventricular hypertrophy: the role of angiotensin II," Circulation Research, vol. 86, no. 4, pp. 463-469, 2000.
34. phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice," Circulation, vol. 105, no. 3, pp. 293-296, 2002.
35. K. K. Griendling, T. J. Murphy, and R. W. Alexander, "Molecular biology of the renin-angiotensin system," Circulation, vol. 87, no. 6, pp. 1816-1828, 1993.
36. K. K. Griendling, D. Sorescu, B. Lassègue, and M. Ushio-Fukai, "Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 10, pp. 2175-2183, 2000.
37. K. K. Griendling and M. Ushio-Fukai, "Reactive oxygen species as mediators of angiotensin II signaling," Regulatory Peptides, vol. 91, no. 1-3, pp. 21-27, 2000.
38. P. J. Pagano, J. K. Clark, M. E. Cifuentes-Pagano, S. M. Clark, G. M. Callis, and M. T. Quinn, "Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II," Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 26, pp. 14483-14488, 1997.
39. H. Zhang, A. Schmeisser, C. D. Garlichs et al., "Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases," Cardiovascular Research, vol. 44, no. 1, pp. 215-222, 1999.
40. M. Zhang, A. L. Kho, N. Anilkumar et al., "Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase," Circulation, vol. 113, no. 9, pp. 1235-1243, 2006.
41. S. Nishio, Y. Teshima, N. Takahashi et al., "Activation of CaMKII as a key regulator of reactive oxygen species production in diabetic rat heart," Journal of Molecular and Cellular Cardiology, vol. 52, no. 5, pp. 1103-1111, 2012.
42. 1 receptor and NADPH oxidase," Hypertension, vol. 42, no. 2, pp. 206-212, 2003.
43. U. Hink, H. Li, H. Mollnau et al., "Mechanisms underlying endothelial dysfunction in diabetes mellitus," Circulation Research, vol. 88, no. 2, pp. E14-E22, 2001.
44. D. H. J. Thijssen, A. J. Maiorana, G. O'Driscoll, N. T. Cable, M. T. E. Hopman, and D. J. Green, "Impact of inactivity and exercise on the vasculature in humans," European Journal of Applied Physiology, vol. 108, no. 5, pp. 845-875, 2010.
45. S. Li, B. Culver, and J. Ren, "Benefit and risk of exercise on myocardial function in diabetes," Pharmacological Research, vol. 48, no. 2, pp. 127-132, 2003.
46. A. Loimaala, H. V. Huikuri, T. Kööbi, M. Rinne, A. Nenonen, and I. Vuori, "Exercise training improves baroreflex sensitivity in type 2 diabetes," Diabetes, vol. 52, no. 7, pp. 1837-1842, 2003.
47. S. Rousseau-Migneron, L. Turcotte, G. Tancrede, and A. Nadeau, "Transient increase in basal insulin levels in severely diabetic rats submitted to physical training," Diabetes Research, vol. 9, no. 2, pp. 97-100, 1988.
48. M. E. Davis, H. Cai, L. McCann, T. Fukai, and D. G. Harrison, "Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 284, no. 4, pp. H1449-H1453, 2003.
49. H. Kohno, S. Furukawa, H. Naito, K. Minamitani, D. Ohmori, and F. Yamakura, "Contribution of nitric oxide, angiotensin II and superoxide dismutase to exercise-induced attenuation of blood pressure elevation in spontaneously hypertensive rats," Japanese Heart Journal, vol. 43, no. 1, pp. 25-34, 2002.
50. R. W. Braith and D. G. Edwards, "Neurohormonal abnormalities in heart failure: impact of exercise training," Congestive Heart Failure, vol. 9, no. 2, pp. 70-76, 2003.
51. T. L. Llewellyn, N. M. Sharma, H. Zheng, and K. P. Patel, "Effects of exercise training on SFO-mediated sympathoexcitation during chronic heart failure," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 306, no. 1, pp. H121-H131, 2014.
52. C. E. Negrao, M. C. Irigoyen, E. D. Moreira, P. C. Brum, P. M. Freire, and E. M. Krieger, "Effect of exercise training on RSNA, baroreflex control, and blood pressure responsiveness," The American Journal of Physiology, vol. 265, no. 2, part 2, pp. R365-R370, 1993.
53. I. H. Zucker and R. U. Pliquett, "Novel mechanisms of sympatho-excitation in chronic heart failure," Heart Failure Monitor, vol. 3, no. 1, pp. 2-7, 2002.
54. K. Husain, "Interaction of physical training and chronic nitroglycerin treatment on blood pressure, nitric oxide, and oxidants/antioxidants in the rat heart," Pharmacological Research, vol. 48, no. 3, pp. 253-261, 2003.
55. T. Fukai, M. R. Siegfried, M. Ushio-Fukai, Y. Cheng, G. Kojda, and D. G. Harrison, "Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training," Journal of Clinical Investigation, vol. 105, no. 11, pp. 1631-1639, 2000.
56. S. K. Powers, S. L. Lennon, J. Quindry, and J. L. Mehta, "Exercise and cardioprotection," Current Opinion in Cardiology, vol. 17, no. 5, pp. 495-502, 2002.
57. I. Fridovich, "The biology of oxygen radicals," Science, vol. 201, no. 4359, pp. 875-880, 1978.
58. R. Balzan, D. R. Agius, and W. H. Bannister, "Cloned prokaryotic iron superoxide dismutase protects yeast cells against oxidative stress depending on mitochondrial location," Biochemical and Biophysical Research Communications, vol. 256, no. 1, pp. 63-67, 1999.
59. T. I. Musch and J. A. Terrell, "Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 262, no. 2, pp. H411-H419, 1992.
60. K. R. Bidasee, H. Zheng, C.-H. Shao, S. K. Parbhu, G. J. Rozanski, and K. P. Patel, "Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of beta-adrenoceptors," Journal of Applied Physiology, vol. 105, no. 3, pp. 907-914, 2008.
61. P. A. Srere, "[1] Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)]," Methods in Enzymology, vol. 13, pp. 3-11, 1969.
62. N. M. Sharma, H. Zheng, P. P. Mehta, Y.-F. Li, and K. P. Patel, "Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II," Cardiovascular Research, vol. 92, no. 2, pp. 348-357, 2011.
63. 1 receptors in neurons," American Journal of Physiology: Cell Physiology, vol. 302, no. 8, pp. C1162-C1173, 2012.
64. P. M. Siu, D. A. Donley, R. W. Bryner, and S. E. Alway, "Citrate synthase expression and enzyme activity after endurance training in cardiac and skeletal muscles," Journal of Applied Physiology, vol. 94, no. 2, pp. 555-560, 2003.
65. S. Levrand, C. Vannay-Bouchiche, B. Pesse et al., "Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo," Free Radical Biology and Medicine, vol. 41, no. 6, pp. 886-895, 2006.
66. V. J. Dzau, "Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis," Hypertension, vol. 37, no. 4, pp. 1047-1052, 2001.
67. T. Fukui, N. Ishizaka, S. Rajagopalan et al., "p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats," Circulation Research, vol. 80, no. 1, pp. 45-51, 1997.
68. phox in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-α," Circulation Research, vol. 90, no. 2, pp. 143-150, 2002.
69. B. M. Babior, "NADPH oxidase: an update," Blood, vol. 93, no. 5, pp. 1464-1476, 1999.
70. I. A. Williams and D. G. Allen, "The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 293, no. 3, pp. H1969-H1977, 2007.
71. M. Shimizu, K. Umeda, N. Sugihara et al., "Collagen remodelling in myocardia of patients with diabetes," Journal of Clinical Pathology, vol. 46, no. 1, pp. 32-36, 1993.
72. P. J. Lijnen, J. F. van Pelt, and R. H. Fagard," Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts," Cardiovascular Therapeutics, vol. 30, no. 1, pp.e1-e8, 2012.
73. J. Kasznicki and J. Drzewoski, "Heart failure in the diabetic population - pathophysiology, diagnosis and management," Archives of Medical Science, vol. 10, no. 3, pp. 546-556, 2014.
74. P. De Feo and P. Schwarz, "Is physical exercise a core therapeutical element for most patients with type 2 diabetes?" Diabetes Care, vol. 36, supplement 2, pp. S149-S154, 2013.
75. J. Myers, M. Prakash, V. Froelicher, D. Do, S. Partington, and J. Edwin Atwood, "Exercise capacity and mortality among men referred for exercise testing," The New England Journal of Medicine, vol. 346, no. 11, pp. 793-801, 2002.
76. J. M. Goguen and L. A. Leiter, "Lipids and diabetes mellitus: a review of therapeutic options," Current Medical Research and Opinion, vol. 18, supplement 1, pp. s58-s74, 2002.
77. H. Zheng, N. M. Sharma, X. Liu, and K. P. Patel, "Exercise training normalizes enhanced sympathetic activation from the paraventricular nucleus in chronic heart failure: role of angiotensin II," American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 303, no. 4, pp. R387-R394, 2012.
78. J. W. E. Rush, J. R. Turk, and M. H. Laughlin, "Exercise training regulates SOD-1 and oxidative stress in porcine aortic endothelium," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 284, no. 4, pp. H1378-H1387, 2003.
79. K. Husain and S. R. Hazelrigg, "Oxidative injury due to chronic nitric oxide synthase inhibition in rat: effect of regular exercise on the heart," Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1587, no. 1, pp. 75-82, 2002.
80. N. Shanmugam, M. A. Reddy, M. Guha, and R. Natarajan, "High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells," Diabetes, vol. 52, no. 5, pp. 1256-1264, 2003.
81. S. Rajagopalan, S. Kurz, T. Münzel et al., "Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone," The Journal of Clinical Investigation, vol. 97, no. 8, pp. 1916-1923, 1996.
82. A. M. W. Petersen and B. K. Pedersen, "The anti-inflammatory effect of exercise," Journal of Applied Physiology, vol. 98, no. 4, pp. 1154-1162, 2005.
83. W. Aldhahi and O. Hamdy, "Adipokines, inflammation, and the endothelium in diabetes," Current Diabetes Reports, vol. 3, no. 4, pp. 293-298, 2003.
84. M. Straczkowski, I. Kowalska, S. Dzienis-Straczkowska et al., "Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance," European Journal of Endocrinology, vol. 145, no. 3, pp. 273-280, 2001.
85. Z. Guo, Z. Xia, J. Jiang, and J. H. McNeill, "Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine," American Journal of Physiology: Heart and Circulatory Physiology, vol. 292, no. 4, pp. H1728-H1736, 2007.